Stefan D. Anker
AuthID: R-00H-F3B
31
TITLE: Cardiac and Kidney Benefits of Empagliflozin in Heart Failure Across the Spectrum of Kidney Function. Insights From EMPEROR-Reduced
AUTHORS: Faiez Zannad; João Pedro Ferreira ; Stuart J Pocock; Cordula Zeller; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Sibylle Jenny Hauske; Martina Brueckmann; Egon Pfarr; Janet Schnee; Christoph Wanner; Milton Packer;
PUBLISHED: 2021, SOURCE: Circulation, VOLUME: 143, ISSUE: 4
AUTHORS: Faiez Zannad; João Pedro Ferreira ; Stuart J Pocock; Cordula Zeller; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Sibylle Jenny Hauske; Martina Brueckmann; Egon Pfarr; Janet Schnee; Christoph Wanner; Milton Packer;
PUBLISHED: 2021, SOURCE: Circulation, VOLUME: 143, ISSUE: 4
32
TITLE: Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction. The EMPEROR-Reduced Trial
AUTHORS: Milton Packer; Stefan D Anker; Javed Butler; Gerasimos Filippatos; João Pedro Ferreira ; Stuart J Pocock; Peter Carson; Inder Anand; Wolfram Doehner; Markus Haass; Michel Komajda; Alan Miller; Steen Pehrson; John R Teerlink; Martina Brueckmann; Waheed Jamal; Cordula Zeller; Sven Schnaidt; Faiez Zannad;
PUBLISHED: 2021, SOURCE: Circulation, VOLUME: 143, ISSUE: 4
AUTHORS: Milton Packer; Stefan D Anker; Javed Butler; Gerasimos Filippatos; João Pedro Ferreira ; Stuart J Pocock; Peter Carson; Inder Anand; Wolfram Doehner; Markus Haass; Michel Komajda; Alan Miller; Steen Pehrson; John R Teerlink; Martina Brueckmann; Waheed Jamal; Cordula Zeller; Sven Schnaidt; Faiez Zannad;
PUBLISHED: 2021, SOURCE: Circulation, VOLUME: 143, ISSUE: 4
33
TITLE: Effect of Empagliflozin on Cardiovascular and Renal Outcomes in Patients With Heart Failure by Baseline Diabetes Status. Results From the EMPEROR-Reduced Trial
AUTHORS: Stefan D Anker; Javed Butler; Gerasimos Filippatos; Muhammad Shahzeb Khan; Nikolaus Marx; Carolyn S.P Lam; Sven Schnaidt; Anne Pernille Ofstad; Martina Brueckmann; Waheed Jamal; Edimar A Bocchi; Piotr Ponikowski; Sergio V Perrone; James L Januzzi; Subodh Verma; Michael Böhm; João Pedro Ferreira ; Stuart J Pocock; Faiez Zannad; Milton Packer;
PUBLISHED: 2021, SOURCE: Circulation, VOLUME: 143, ISSUE: 4
AUTHORS: Stefan D Anker; Javed Butler; Gerasimos Filippatos; Muhammad Shahzeb Khan; Nikolaus Marx; Carolyn S.P Lam; Sven Schnaidt; Anne Pernille Ofstad; Martina Brueckmann; Waheed Jamal; Edimar A Bocchi; Piotr Ponikowski; Sergio V Perrone; James L Januzzi; Subodh Verma; Michael Böhm; João Pedro Ferreira ; Stuart J Pocock; Faiez Zannad; Milton Packer;
PUBLISHED: 2021, SOURCE: Circulation, VOLUME: 143, ISSUE: 4
34
TITLE: Concentration‐Dependent
Clinical and Prognostic Importance of
High‐Sensitivity
Cardiac Troponin T in Heart Failure and a Reduced Ejection Fraction and the Influence of Empagliflozin: the
EMPEROR‐Reduced
Trial
AUTHORS: Milton Packer; James L Januzzi; Joao Pedro Ferreira ; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Martina Brueckmann; Waheed Jamal; Daniel Cotton; Tomoko Iwata; Faiez Zannad;
PUBLISHED: 2021, SOURCE: European Journal of Heart Failure
AUTHORS: Milton Packer; James L Januzzi; Joao Pedro Ferreira ; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Martina Brueckmann; Waheed Jamal; Daniel Cotton; Tomoko Iwata; Faiez Zannad;
PUBLISHED: 2021, SOURCE: European Journal of Heart Failure
35
TITLE: New-onset atrial fibrillation in patients with worsening heart failure and coronary artery disease: an analysis from the COMMANDER-HF trial Full Text
AUTHORS: João Pedro Ferreira ; John G Cleland; Carolyn S P Lam; Stefan D Anker; Mandeep R Mehra; Dirk J van Veldhuisen; William M Byra; David A LaPolice; Barry Greenberg; Faiez Zannad;
PUBLISHED: 2021, SOURCE: Clinical Research in Cardiology
AUTHORS: João Pedro Ferreira ; John G Cleland; Carolyn S P Lam; Stefan D Anker; Mandeep R Mehra; Dirk J van Veldhuisen; William M Byra; David A LaPolice; Barry Greenberg; Faiez Zannad;
PUBLISHED: 2021, SOURCE: Clinical Research in Cardiology
36
TITLE: Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial
AUTHORS: Carolyn S P Lam; João Pedro Ferreira ; Egon Pfarr; David Sim; Hiroyuki Tsutsui; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Naveed Sattar; Subodh Verma; Martina Brueckmann; Janet Schnee; Daniel Cotton; Faiez Zannad; Milton Packer;
PUBLISHED: 2021, SOURCE: European Heart Journal
AUTHORS: Carolyn S P Lam; João Pedro Ferreira ; Egon Pfarr; David Sim; Hiroyuki Tsutsui; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; Naveed Sattar; Subodh Verma; Martina Brueckmann; Janet Schnee; Daniel Cotton; Faiez Zannad; Milton Packer;
PUBLISHED: 2021, SOURCE: European Heart Journal
37
TITLE: Novel biomarker-driven prognostic models to predict morbidity and mortality in chronic heart failure: the EMPEROR-Reduced trial
AUTHORS: Pocock, Stuart J.; Ferreira, Joao Pedro ; Gregson, John; Anker, Stefan D.; Butler, Javed; Filippatos, Gerasimos; Gollop, Nicholas D.; Iwata, Tomoko; Brueckmann, Martina; Januzzi, James L., Jr.; Voors, Adriaan A.; Zannad, Faiez; Packer, Milton;
PUBLISHED: 2021, SOURCE: EUROPEAN HEART JOURNAL, VOLUME: 42, ISSUE: 43
AUTHORS: Pocock, Stuart J.; Ferreira, Joao Pedro ; Gregson, John; Anker, Stefan D.; Butler, Javed; Filippatos, Gerasimos; Gollop, Nicholas D.; Iwata, Tomoko; Brueckmann, Martina; Januzzi, James L., Jr.; Voors, Adriaan A.; Zannad, Faiez; Packer, Milton;
PUBLISHED: 2021, SOURCE: EUROPEAN HEART JOURNAL, VOLUME: 42, ISSUE: 43
38
TITLE: Influence of endpoint definitions on the effect of empagliflozin on major renal outcomes in the EMPEROR-Preserved trial
AUTHORS: Packer, M; Zannad, F; Butler, J; Filippatos, G; Ferreira, JP ; Pocock, SJ; Brueckmann, M; Zeller, C; Hauske, S; Anker, SD;
PUBLISHED: 2021, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 23, ISSUE: 10
AUTHORS: Packer, M; Zannad, F; Butler, J; Filippatos, G; Ferreira, JP ; Pocock, SJ; Brueckmann, M; Zeller, C; Hauske, S; Anker, SD;
PUBLISHED: 2021, SOURCE: EUROPEAN JOURNAL OF HEART FAILURE, VOLUME: 23, ISSUE: 10
39
TITLE: Prognostic Importance of NT-proBNP and Effect of Empagliflozin in the EMPEROR-Reduced Trial Full Text
AUTHORS: James L Januzzi; Faiez Zannad; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; João Pedro Ferreira ; Naveed Sattar; Subodh Verma; Ola Vedin; Janet Schnee; Tomoko Iwata; Dan Cotton; Milton Packer;
PUBLISHED: 2021, SOURCE: Journal of the American College of Cardiology, VOLUME: 78, ISSUE: 13
AUTHORS: James L Januzzi; Faiez Zannad; Stefan D Anker; Javed Butler; Gerasimos Filippatos; Stuart J Pocock; João Pedro Ferreira ; Naveed Sattar; Subodh Verma; Ola Vedin; Janet Schnee; Tomoko Iwata; Dan Cotton; Milton Packer;
PUBLISHED: 2021, SOURCE: Journal of the American College of Cardiology, VOLUME: 78, ISSUE: 13
40
TITLE: Empagliflozin Improves Cardiovascular and Renal Outcomes in Heart Failure Irrespective of Systolic Blood Pressure Full Text
AUTHORS: Michael Böhm; Stefan D Anker; Javed Butler; Gerasimos Filippatos; João Pedro Ferreira ; Stuart J Pocock; Felix Mahfoud; Martina Brueckmann; Waheed Jamal; Anne Pernille Ofstad; Elke Schüler; Piotr Ponikowski; Christoph Wanner; Faiez Zannad; Milton Packer;
PUBLISHED: 2021, SOURCE: Journal of the American College of Cardiology, VOLUME: 78, ISSUE: 13
AUTHORS: Michael Böhm; Stefan D Anker; Javed Butler; Gerasimos Filippatos; João Pedro Ferreira ; Stuart J Pocock; Felix Mahfoud; Martina Brueckmann; Waheed Jamal; Anne Pernille Ofstad; Elke Schüler; Piotr Ponikowski; Christoph Wanner; Faiez Zannad; Milton Packer;
PUBLISHED: 2021, SOURCE: Journal of the American College of Cardiology, VOLUME: 78, ISSUE: 13
